Neuroprotective actions of a fatty acid nitroalkene in Parkinson’s disease

To date there are no therapeutic strategies that limit the progression of Parkinson’s disease (PD). The mechanisms underlying PD-related nigrostriatal neurodegeneration remain incompletely understood, with multiple factors modulating the course of PD pathogenesis. This includes Nrf2-dependent gene e...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Maio, Roberto, Keeney, Matthew T., Cechova, Veronika, Mortimer, Amanda, Sekandari, Ahssan, Rowart, Pascal, Greenamyre, J. Timothy, Freeman, Bruce A., Fazzari, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10082007/
https://www.ncbi.nlm.nih.gov/pubmed/37029127
http://dx.doi.org/10.1038/s41531-023-00502-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10082007/
https://www.ncbi.nlm.nih.gov/pubmed/37029127
http://dx.doi.org/10.1038/s41531-023-00502-3

Ejemplares similares